01 October 2022 : Editorial
Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir
DOI: 10.12659/MSM.938532
Med Sci Monit 2022; 28:e938532
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
01 October 2022 : Editorial
DOI: 10.12659/MSM.938532
Med Sci Monit 2022; 28:e938532
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.